Skip to main content
Premium Trial:

Request an Annual Quote

Veridex to Market Qiagen s Sample Prep Kit with Molecular Dx Offering

NEW YORK, April 18 (GenomeWeb News) - Qiagen said today that Veridex, a Johnson & Johnson subsidiary, will market a "custom version" of Qiagen's RNeasy nucleic acid purification kit as part of its molecular diagnostics offering.

 

Qiagen said that Veridex will sell the RNeasy technology under its GeneSearch trademark for use in purifiying RNA from lymph node specimens excised for oncology testing and monitoring during surgery.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.